Search Results - "Digumarthy, S."

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression by Aguilar, E.J., Ricciuti, B., Gainor, J.F., Kehl, K.L., Kravets, S., Dahlberg, S., Nishino, M., Sholl, L.M., Adeni, A., Subegdjo, S., Khosrowjerdi, S., Peterson, R.M., Digumarthy, S., Liu, C., Sauter, J., Rizvi, H., Arbour, K.C., Carter, B.W., Heymach, J.V., Altan, M., Hellmann, M.D., Awad, M.M.

“…In non-small-cell lung cancers with programmed death-ligand 1 (PD-L1) expression on ≥50% of tumor cells, first-line treatment with the PD-1 inhibitor…”
Get full text

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50 by Gainor, J.F., Rizvi, H., Jimenez Aguilar, E., Skoulidis, F., Yeap, B.Y., Naidoo, J., Khosrowjerdi, S., Mooradian, M., Lydon, C., Illei, P., Zhang, J., Peterson, R., Ricciuti, B., Nishino, M., Zhang, J., Roth, J.A., Grishman, J., Anderson, D., Little, B.P., Carter, B.W., Arbour, K., Sauter, J.L., Mino-Kenudson, M., Heymach, J.V., Digumarthy, S., Shaw, A.T., Awad, M.M., Hellmann, M.D.

“…Immune checkpoint inhibitors (ICIs) are standard therapies for patients with advanced non-small-cell lung cancer (NSCLC) and a programmed death-ligand 1…”
Get full text

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice by Sequist, L.V., Heist, R.S., Shaw, A.T., Fidias, P., Rosovsky, R., Temel, J.S., Lennes, I.T., Digumarthy, S., Waltman, B.A., Bast, E., Tammireddy, S., Morrissey, L., Muzikansky, A., Goldberg, S.B., Gainor, J., Channick, C.L., Wain, J.C., Gaissert, H., Donahue, D.M., Muniappan, A., Wright, C., Willers, H., Mathisen, D.J., Choi, N.C., Baselga, J., Lynch, T.J., Ellisen, L.W., Mino-Kenudson, M., Lanuti, M., Borger, D.R., Iafrate, A.J., Engelman, J.A., Dias-Santagata, D.

“…Personalizing non-small-cell lung cancer (NSCLC) therapy toward oncogene addicted pathway inhibition is effective. Hence, the ability to determine a more…”
Get full text

Qualitative and quantitative DECT pulmonary angiography in COVID-19 pneumonia and pulmonary embolism by Arru, C.D., Digumarthy, S.R., Hansen, J.V., Lyhne, M.D., Singh, R., Rosovsky, R., Nielsen-Kudsk, J.E., Kabrhel, C., Saba, L., Kalra, M.K.

“…To assess differences in qualitative and quantitative parameters of pulmonary perfusion from dual-energy computed tomography (CT) pulmonary angiography…”
Get full text

Real world cfDNA collection in EGFR-mutant NSCLC by Marcoux, N., Sequist, L.V., Hata, A., Banwait, M., Dagogo-Jack, I., Nagy, R., Lanman, R.B., Muzikansky, A., Digumarthy, S.R., Piotrowska, Z.

Get full text

Significance of internal mammary lymph nodes in patients after mastectomy with tissue-expander reconstruction: a case–control study by Kaewlai, R, Digumarthy, S.R, Smith, B.L, Corben, A.D, Austen, W.G, Shepard, J.-A.O, Sharma, A

“…Aim To retrospectively assess the frequency of internal mammary lymph nodes (IMNs) in patients after mastectomy and tissue-expander reconstruction. Materials…”
Get full text

MRI in detection of hepatocellular carcinoma (HCC) by Digumarthy, Subba R, Sahani, Dushyant V, Saini, Sanjay

“…Hepatocellular carcinoma (HCC) is the commonest malignancy of the liver and is usually due to cirrhosis. Early detection of HCC and the premalignant dysplastic…”
Get full text

1346PReal world cfDNA collection in EGFR-mutant NSCLC by Marcoux, N, Sequist, L V, Hata, A, Banwait, M, Dagogo-Jack, I, Nagy, R, Lanman, R B, Muzikansky, A, Digumarthy, S R, Piotrowska, Z

Get full text

C78 FIBROSIS: MEDIATORS AND MODULATORS: Use Of Gadofosveset-Enhanced Lung Mri To Assess Ongoing Lung Injury In Fibrotic Interstitial Lung Disease by Montesi, S, Rao, R, Liang, L, Caravan, P, Sharma, A, Digumarthy, S, Seethamraju, R, Tager, A M

“…Signal intensity was measured in standardized Regions of Interest (ROIs) in three regions (anterior, medial, and posterior) in the upper, middle, and lower…”
Get full text

Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy by Piotrowska, Z, Stirling, K, Heist, R, Campo, M, Rizzo, C, Digumarthy, S.R, Lanuti, M, Fintelmann, F.J, Lennes, I, Farago, A, Gainor, J, Azzoli, C.G, Temel, J, Mino-Kenudson, M, Dias-Santagata, D, Corcoran, R, Shaw, A, Engelman, J.A, Hata, A, Sequist, L.V

Get full text

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression by Aguilar, E J, Ricciuti, B, Gainor, J F, Kehl, K L, Kravets, S, Dahlberg, S, Nishino, M, Sholl, L M, Adeni, A, Subegdjo, S, Khosrowjerdi, S, Peterson, R M, Digumarthy, S, Liu, C, Sauter, J, Rizvi, H, Arbour, K C, Carter, B W, Heymach, J V, Altan, M, Hellmann, M D, Awad, M M

“…In non-small-cell lung cancers with programmed death-ligand 1 (PD-L1) expression on ≥50% of tumor cells, first-line treatment with the PD-1 inhibitor…”
Get full text

Clinicopathologic features of EML4-ALK mutant lung cancer by Shaw, A. T., Costa, D., Mino-Kenudson, M., Digumarthy, S., Yeap, B. Y., Admane, S., Rodig, S., Chirieac, L., Iafrate, A. J., Lynch, T. J.

“…Abstract only 11021 Background: EML4-ALK is a novel fusion oncogene in non-small cell lung cancer (NSCLC). The fusion results from a small inversion within…”
Get full text

Radiation dose reduction with chest computed tomography using adaptive statistical iterative reconstruction technique: initial experience by Prakash, Priyanka, Kalra, Mannudeep K, Digumarthy, Subba R, Hsieh, Jiang, Pien, Homer, Singh, Sarabjeet, Gilman, Matthew D, Shepard, Jo-Anne O

“…To assess radiation dose reduction and image quality for weight-based chest computed tomographic (CT) examination results reconstructed using adaptive…”
Get full text

Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors by Sharma, Amita, Lanuti, Michael, He, Wei, Palmer, Edwin L, Shepard, Jo-Anne O, Digumarthy, Subba R

“…The objective of this study was to evaluate the F-fluorodeoxyglucose positron emission tomography (F-FDG-PET) findings following complete radiofrequency…”
Get full text

Dual-energy computed tomographic pulmonary angiography: a pilot study to assess the effect on image quality and diagnostic confidence by Sangwaiya, Minal J, Kalra, Mannudeep K, Sharma, Amita, Halpern, Elkan F, Shepard, Jo-Anne O, Digumarthy, Subba R

“…The aim of this study was to assess if dual-energy computed tomographic pulmonary angiography (DE-CTPA) protocol performed on a dual-source CT scanner can…”
Get full text

Imaging findings of pericardial metastasis on chest computed tomography by Prakash, Priyanka, Kalra, Mannudeep K, Stone, James R, Shepard, Jo-Anne O, Digumarthy, Subba R

“…To assess imaging features of pericardial metastases on chest computed tomography (CT) scanning. This institutional review board-approved retrospective study…”
Get full text

Haemangiopericytoma of the Internal Jugular Vein: an Unusual Neck Mass by Rao Digumarthy, S., Peri, N., Devi Malladi, U., Mohan Reddy Jinna, J., Sundaram, C.

Get full text

Imaging of thoracic malignancies by Digumarthy, Subba R, Aquino, Suzanne L

Get more information

Fluorodeoxyglucose positron emission tomography pattern of pulmonary lymphangitic carcinomatosis by Digumarthy, Subba R, Fischman, Alan J, Kwek, Boon Han, Aquino, Suzanne L

“…The purpose of this study was to evaluate the F-fluorodeoxyglucose (FDG) positron emission tomography (PET) uptake in pulmonary lymphangitic carcinomatosis…”
Get full text